AI assistant
AMPOL LIMITED — M&A Activity 2026
Apr 22, 2026
64361_rns_2026-04-22_3bc72638-5db5-4873-ba20-ae60edf279d6.pdf
M&A Activity
Open in viewerOpens in your device viewer
ASX Release
AMPOL
23 April 2026
EG ACQUISITION FINAL REMEDY OFFER TO ADDRESS COMPETITION CONCERNS
On 22 April 2026, Ampol lodged a final remedy offer with the Australian Competition & Consumer Commission (ACCC) in connection with its proposed acquisition of EG Australia.
The final remedy offer includes four (4) additional sites to be divested, taking the total remedy offered by Ampol from 37 to 41 sites. This marks an important milestone in the process and follows further constructive engagement with the ACCC. Ampol has included these additional sites with a view to finalising the regulatory process expeditiously.
Ampol intends to divest the sites as a package and has identified, and materially progressed discussions with, potential buyers.
The Phase 2 ACCC determination is required to be made no later than 5 June 2026 (subject to an extension of up to 15 Business Days at the discretion of the ACCC). The transaction is targeted for completion in mid-2026 subject to receiving ACCC clearance and completing other conditions precedent.
Authorised for release by: the Disclosure Officers of Ampol Limited
AMPOL LIMITED
ACN 004 201 307
29-33 BOURKE ROAD
ALEXANDRIA NSW 2015
INVESTOR CONTACT
FRAN VAN REYK
GENERAL MANAGER INVESTOR
RELATIONS AND SUSTAINABILITY
M +61 419 871138
[email protected]
MEDIA CONTACT
MATT PATERSON
EXTERNAL COMMUNICATIONS MANAGER
M +61 402 140 757
[email protected]